comprehensive -WSS

comprehensive

author：focus 2025-09-30 01:14:13 - browse：65929

Sarepta - Cambridge -AP — Kristoffer Tripplaar/Sipa via AP

The Food and Drug Administration granted conditional approval Thursday to the first gene therapy for Duchenne muscular dystrophy. Regulators restricted the treatment to younger patients, with additional data required to broaden its use.

The gene therapy, called Elevydis, is made by Sarepta Therapeutics. The company will charge $3.2 million for the treatment, making it the U.S.’s second most expensive drug, behind a recently approved gene therapy for hemophilia. CEO Doug Ingram said on a conference call the price was below what a recently published company-funded analysis found would be cost-effective.

“The approval of Elevidys is a watershed moment for the treatment of Duchenne. Elevydis is the first and only gene therapy approved for Duchenne, and this approval brings us closer to our goal of bringing forward a treatment that provides the potential to alter the trajectory of this degenerative disease,” Ingram said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： Medical schools are missing the mark on artificial intelligence

WSS

California Joshua trees severely burned in massive wildfire

In utero gene editing: an explainer

A new nitrogen execution bill also undermines medical licensing

With competition flaring, obesity drug hits goal in liver disease study

California Joshua trees severely burned in massive wildfire

Flash flooding emergencies prompt evacuations in Kentucky, Tennessee

leisure time

comprehensive

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Pharma needs to include young adults in clinical research

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Does Medicare's free annual wellness visit do any good?

Medical leaders decry Supreme Court decision on affirmative action

Lifetime voting ban for felony convictions struck down in Mississippi

Drug repurposing or repositioning? The language matters

California Joshua trees severely burned in massive wildfire

entertainment

Medical schools are missing the mark on artificial intelligence

Russian court extends detention of American musician

Antivenom research: Lessons from HIV applied in search for universal antidote

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

A new nitrogen execution bill also undermines medical licensing

Community Health Systems hospitals under DOJ investigation

hotspot

Wikipedia

hotspot

knowledge